© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 1, 25-31,
January 6, 1993
© 1993 Oxford University Press
Breast Cancer After Treatment of Hodgkin's Disease
Department of Radiation Oncology, Stanford University School of Medicine Stanford, Calif.
Division of Cancer Etiology, National Cancer Institute Bethesda, Md.
Correspondence to: Steven L. Hancock, M.D., Department of Radiation Oncology, Stanford University Medical Center, A089, Stanford, CA 94305.
Background: Most studies of survivors of Hodgkin's disease have shown a low risk for subsequent breast cancer, even though much lower doses of radiation than those used for Hodgkin's disease have been shown to induce breast cancer in other settings. Purpose: This study quantifies the risk of breast cancer following Hodgkin's disease treatment according to age at treatment and type of treatment. Methods: To evaluate the risk of breast cancer from irradiation, we reviewed records of 885 women treated for Hodgkin's disease between 1961 and 1990 (mean follow-up, 10 years). Risks for breast cancer incidence and mortality were calculated by comparison with expected rates for a general female population matched by age and race. Results: Twenty-five patients have developed invasive breast cancer, yielding a relative risk (RR) of 4.1 (95% confidence interval [CI] = 2.5-5.7). An additional patient developed multifocal carcinoma in situ. Age at irradiation strongly influenced risk: RR was 136 for women treated before 15 years of age (95% CI = 34-371). RR declined with age at irradiation (P for trend <.0001), but the elevation remained statistically significant for subjects less than 30 years old at the time of irradiation (for those 15-24, RR = 19 [95% CI = 10.3-32]; for those 24-29, RR = 7 [95% CI = 3.2-14.4]). In women above 30 years of age, the risk was not elevated (RR = 0.7; 95% CI = 0.2-1.8). Risk of breast cancer increased significantly with time since treatment (P for trend <.0001). The RR was 2.0 (95% CI = 1.0-3.5) with follow-up under 15 years and 13.6 (95% CI = 7.9-18.2) with follow-up equal to or exceeding 15 years. The addition of mechlorethamine, vincristine, procarbazine, and prednisone chemotherapy to irradiation increased the risk within the first 15 years. Most breast cancers (22 of 26) arose within or at the margin of the radiation field and were infiltrating ductal carcinomas. Stage distribution and outcome suggest that the increased incidence was not solely attributable to vigilant screening. RR of death from breast cancer was 5.1 (95% CI = 2.2-10.0). Conclusions: Women treated for Hodgkin's disease with radiation before 30 years of age are at markedly increased risk for breast cancer, with risk increasing dramatically more than 15 years after therapy. Implications: The high RR for development of breast cancer in women exposed to therapeutic radiation under 30 years of age raises important issues about optimal treatment strategies for patients with Hodgkin's disease, breast cancer, and other cancers. [J Natl Cancer Inst 85: 25–31, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Crump and D. Hodgson Secondary Breast Cancer in Hodgkin's Lymphoma Survivors J. Clin. Oncol., September 10, 2009; 27(26): 4229 - 4231. [Full Text] [PDF]
|
|
|
|
|
|
P. D. Inskip, L. L. Robison, M. Stovall, S. A. Smith, S. Hammond, A. C. Mertens, J. A. Whitton, L. Diller, L. Kenney, S. S. Donaldson, et al. Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study J. Clin. Oncol., August 20, 2009; 27(24): 3901 - 3907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Oeffinger, J. S. Ford, C. S. Moskowitz, L. R. Diller, M. M. Hudson, J. F. Chou, S. M. Smith, A. C. Mertens, T. O. Henderson, D. L. Friedman, et al. Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer JAMA, January 28, 2009; 301(4): 404 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Mahoney, T. Bevers, E. Linos, and W. C. Willett Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction CA Cancer J Clin, November 3, 2008; (2008) CA.2008.0016v1. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Lee, M. Pintilie, D. C. Hodgson, P. E. Goss, and M. Crump Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma Ann. Onc., January 1, 2008; 19(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Stinchcombe, R. Walters, A. H. Khandani, and M. A. Socinksi Radiation-Induced Sarcoma After High-Dose Thoracic Radiation Therapy in Non-Small-Cell Lung Cancer J. Clin. Oncol., April 20, 2007; 25(12): 1621 - 1623. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 516 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Dickerman The Late Effects of Childhood Cancer Therapy Pediatrics, March 1, 2007; 119(3): 554 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Sanna, K Lorizzo, N Rotmensz, V Bagnardi, S Cinieri, M Colleoni, F Nole, and A Goldhirsch Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors Ann. Onc., February 1, 2007; 18(2): 288 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Castiglioni, M. Terenziani, M. L. Carcangiu, R. Miliano, P. Aiello, L. Bertola, T. Triulzi, P. Gasparini, T. Camerini, G. Sozzi, et al. Radiation Effects on Development of HER2-Positive Breast Carcinomas Clin. Cancer Res., January 1, 2007; 13(1): 46 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Franklin, A Pluetschow, M Paus, L Specht, A-P Anselmo, A Aviles, G Biti, T Bogatyreva, G Bonadonna, C Brillant, et al. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials Ann. Onc., December 1, 2006; 17(12): 1749 - 1760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brusamolino, A. Baio, E. Orlandi, L. Arcaini, F. Passamonti, V. Griva, W. Casagrande, C. Pascutto, P. Franchini, and M. Lazzarino Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuvant Radiotherapy: A Single-Institution 15-Year Follow-up. Clin. Cancer Res., November 1, 2006; 12(21): 6487 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Noordijk, P. Carde, N. Dupouy, A. Hagenbeek, A. D.G. Krol, J. C. Kluin-Nelemans, U. Tirelli, M. Monconduit, J. Thomas, H. Eghbali, et al. Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials J. Clin. Oncol., July 1, 2006; 24(19): 3128 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Moser, E. M. Noordijk, F. E. van Leeuwen, S. le Cessie, J. W. Baars, J. Thomas, P. Carde, J. H. Meerwaldt, M. van Glabbeke, and H. C. Kluin-Nelemans Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma Blood, April 1, 2006; 107(7): 2912 - 2919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bassal, A. C. Mertens, L. Taylor, J. P. Neglia, B. S. Greffe, S. Hammond, C. M. Ronckers, D. L. Friedman, M. Stovall, Y. Y. Yasui, et al. Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., January 20, 2006; 24(3): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Johnson, J. A. Radford, M. H. Cullen, M. R. Sydes, J. Walewski, A. S. Jack, K. A. MacLennan, S. P. Stenning, S. Clawson, P. Smith, et al. Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519) J. Clin. Oncol., December 20, 2005; 23(36): 9208 - 9218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Baer, S. J. Schnitt, J. L. Connolly, C. Byrne, W. C. Willett, B. Rosner, and G. A. Colditz Early Life Factors and Incidence of Proliferative Benign Breast Disease Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2889 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Faulkner and J. Law Mammographic breast cancer screening for women previously treated with high breast doses for diseases such as Hodgkin's Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 330 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Travis, D. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, E. Pukkala, C. F. Lynch, et al. Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma J Natl Cancer Inst, October 5, 2005; 97(19): 1428 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Brennan, T. Gleeson, L. E. Coate, C. Cronin, D. Carney, and S. J. Eustace A Comparison of Whole-Body MRI and CT for the Staging of Lymphoma Am. J. Roentgenol., September 1, 2005; 185(3): 711 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guibout, E. Adjadj, C. Rubino, A. Shamsaldin, E. Grimaud, M. Hawkins, M.-C. Mathieu, O. Oberlin, J.-M. Zucker, X. Panis, et al. Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood J. Clin. Oncol., January 1, 2005; 23(1): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Landier, S. Bhatia, D. A. Eshelman, K. J. Forte, T. Sweeney, A. L. Hester, J. Darling, F. D. Armstrong, J. Blatt, L. S. Constine, et al. Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline J. Clin. Oncol., December 15, 2004; 22(24): 4979 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Kenney, Y. Yasui, P. D. Inskip, S. Hammond, J. P. Neglia, A. C. Mertens, A. T. Meadows, D. Friedman, L. L. Robison, and L. Diller Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study Ann Intern Med, October 19, 2004; 141(8): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Behringer, A. Josting, P. Schiller, H. T. Eich, H. Bredenfeld, V. Diehl, and A. Engert Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group Ann. Onc., July 1, 2004; 15(7): 1079 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shan, M. Yu, H. A.J. Schut, and E. G. Snyderwine Susceptibility of Rats to Mammary Gland Carcinogenesis by the Food-Derived Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) Varies with Age and Is Associated with the Induction of Differential Gene Expression Am. J. Pathol., July 1, 2004; 165(1): 191 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.-A. Gustafsson, G. Khan, and L. Hilakivi-Clarke Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis Carcinogenesis, May 1, 2004; 25(5): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Ng, S. Li, D. Neuberg, B. Silver, J. Weeks, and P. Mauch Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians Ann. Onc., February 1, 2004; 15(2): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Oeffinger, A. C. Mertens, M. M. Hudson, J. G. Gurney, J. Casillas, H. Chen, J. Whitton, M. Yeazel, Y. Yasui, and L. L. Robison Health Care of Young Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study Ann. Fam. Med, January 1, 2004; 2(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhatia, Y. Yasui, L. L. Robison, J. M. Birch, M. K. Bogue, L. Diller, C. DeLaat, F. Fossati-Bellani, E. Morgan, O. Oberlin, et al. High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin's Disease: Report From the Late Effects Study Group J. Clin. Oncol., December 1, 2003; 21(23): 4386 - 4394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Engert, P. Schiller, A. Josting, R. Herrmann, P. Koch, M. Sieber, F. Boissevain, M. de Wit, J. Mezger, E. Duhmke, et al. Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin's Lymphoma: Results of the HD8 Trial of the German Hodgkin's Lymphoma Study Group J. Clin. Oncol., October 1, 2003; 21(19): 3601 - 3608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Travis, D. A. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. F. Lynch, et al. Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease JAMA, July 23, 2003; 290(4): 465 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yahalom Breast Cancer After Hodgkin Disease: Hope for a Safer Cure JAMA, July 23, 2003; 290(4): 529 - 531. [Full Text] [PDF]
|
|
|
|
|
|
F. E. van Leeuwen, W. J. Klokman, M. Stovall, E. C. Dahler, M. B. van't Veer, E. M. Noordijk, M. A. Crommelin, B. M. P. Aleman, A. Broeks, M. Gospodarowicz, et al. Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease J Natl Cancer Inst, July 2, 2003; 95(13): 971 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Wahner-Roedler, D. F. Nelson, I. T. Croghan, S. J. Achenbach, C. S. Crowson, L. C. Hartmann, and W. M. O'Fallon Risk of Breast Cancer and Breast Cancer Characteristics in Women Treated With Supradiaphragmatic Radiation for Hodgkin Lymphoma: Mayo Clinic Experience Mayo Clin. Proc., June 1, 2003; 78(6): 708 - 715. [Abstract] [PDF]
|
|
|
|
|
|
H. Kattlove and R. J. Winn Ongoing Care of Patients After Primary Treatment for Their Cancer CA Cancer J Clin, May 1, 2003; 53(3): 172 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Foss Abrahamsen, A. Andersen, O. Nome, A. B. Jacobsen, H. Holte, J. Foss Abrahamsen, and S. Kvaloy Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time Ann. Onc., November 1, 2002; 13(11): 1786 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Ng, M. V. P. Bernardo, E. Weller, K. Backstrand, B. Silver, K. C. Marcus, N. J. Tarbell, M. A. Stevenson, J. W. Friedberg, and P. M. Mauch Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Blood, August 28, 2002; 100(6): 1989 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Dores, C. Metayer, R. E. Curtis, C. F. Lynch, E. A. Clarke, B. Glimelius, H. Storm, E. Pukkala, F. E. van Leeuwen, E. J. Holowaty, et al. Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin's Disease: A Population-Based Evaluation Over 25 Years J. Clin. Oncol., August 15, 2002; 20(16): 3484 - 3494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Prosnitz Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin's Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go J. Clin. Oncol., May 1, 2002; 20(9): 2225 - 2228. [Full Text] [PDF]
|
|
|
|
|
|
L. Diller, C. M. Nancarrow, K. Shaffer, U. Matulonis, P. Mauch, D. Neuberg, N. J. Tarbell, H. Litman, and J. Garber Breast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study J. Clin. Oncol., April 15, 2002; 20(8): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Horning, R. T. Hoppe, S. Breslin, N. L. Bartlett, B. W. Brown, and S. A. Rosenberg Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical Trial J. Clin. Oncol., February 1, 2002; 20(3): 630 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Neglia, D. L. Friedman, Y. Yasui, A. C. Mertens, S. Hammond, M. Stovall, S. S. Donaldson, A. T. Meadows, and L. L. Robison Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study J Natl Cancer Inst, April 18, 2001; 93(8): 618 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. van Besien, M. Kelta, and P. Bahaguna Primary Mediastinal B-Cell Lymphoma: A Review of Pathology and Management J. Clin. Oncol., March 15, 2001; 19(6): 1855 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhatia, A. D. Louie, R. Bhatia, M. R. O'Donnell, H. Fung, A. Kashyap, A. Krishnan, A. Molina, A. Nademanee, J. C. Niland, et al. Solid Cancers After Bone Marrow Transplantation J. Clin. Oncol., January 15, 2001; 19(2): 464 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Behrens, L. B. Travis, I. I. Wistuba, S. Davis, A. Maitra, E. A. Clarke, C. F. Lynch, B. Glimelius, T. Wiklund, R. Tarone, et al. Molecular Changes in Second Primary Lung and Breast Cancers after Therapy for Hodgkin's Disease Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1027 - 1035. [Abstract] [Full Text]
|
|
|
|
|
|
C. Metayer, C. F. Lynch, E. A. Clarke, B. Glimelius, H. Storm, E. Pukkala, T. Joensuu, F. E. van Leeuwen, M. B. van't Veer, R. E. Curtis, et al. Second Cancers Among Long-Term Survivors of Hodgkin's Disease Diagnosed in Childhood and Adolescence J. Clin. Oncol., June 12, 2000; 18(12): 2435 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Aisenberg, D. M. Finkelstein, F. E. van Leeuwen, W. J. Klokman, and B. M. P. Aleman Second Malignancies in Hodgkin's Disease J. Clin. Oncol., May 10, 2000; 18(10): 2186 - 2187. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Green, A. Hyland, M. P. Barcos, J. A. Reynolds, R. J. Lee, B. C. Hall, and M. A. Zevon Second Malignant Neoplasms After Treatment for Hodgkin’s Disease in Childhood or Adolescence J. Clin. Oncol., April 7, 2000; 18(7): 1492 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Calaf and T. K. Hei Establishment of a radiation- and estrogen-induced breast cancer model Carcinogenesis, April 1, 2000; 21(4): 769 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Wolden, S. L. Hancock, R. W. Carlson, D. R. Goffinet, S. S. Jeffrey, and R. T. Hoppe Management of Breast Cancer After Hodgkin’s Disease J. Clin. Oncol., February 14, 2000; 18(4): 765 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. van Leeuwen, W. J. Klokman, M. B. v.’t Veer, A. Hagenbeek, A. D. G. Krol, U. A. O. Vetter, M. Schaapveld, P. van Heerde, J. M. V. Burgers, R. Somers, et al. Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood J. Clin. Oncol., February 1, 2000; 18(3): 487 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Swerdlow, J. A. Barber, G. V. Hudson, D. Cunningham, R. K. Gupta, B. W. Hancock, A. Horwich, T. A. Lister, and D. C. Linch Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment J. Clin. Oncol., February 1, 2000; 18(3): 498 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Linch, R. G. Gosden, T. Tulandi, S.-L. Tan, and S. L. Hancock Hodgkin's Lymphoma: Choice of Therapy and Late Complications Hematology, January 1, 2000; 2000(1): 205 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schellong, R. Potter, J. Bramswig, W. Wagner, F.-J. Prott, W. Dorffel, D. Korholz, G. Mann, B. Rath, A. Reiter, et al. High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90 J. Clin. Oncol., December 1, 1999; 17(12): 3736 - 3744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Ng, J. C. Weeks, P. M. Mauch, and K. M. Kuntz Decision Analysis on Alternative Treatment Strategies for Favorable-Prognosis, Early-Stage Hodgkin's Disease J. Clin. Oncol., November 1, 1999; 17(11): 3577 - 3585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Nichols, S. Levitz, K. E. Shannon, D. C.R. Wahrer, D. W. Bell, G. Chang, S. Hegde, D. Neuberg, T. Shafman, N. J. Tarbell, et al. Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease J. Clin. Oncol., April 1, 1999; 17(4): 1259 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Aisenberg Problems in Hodgkin's Disease Management Blood, February 1, 1999; 93(3): 761 - 779. [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Teirstein, V. Massullo, S. Jani, R. J. Russo, D. A. Cloutier, R. A. Schatz, E. M. Guarneri, S. Steuterman, K. Sirkin, S. Norman, et al. Two-Year Follow-Up After Catheter-Based Radiotherapy to Inhibit Coronary Restenosis Circulation, January 19, 1999; 99(2): 243 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wirth, M. Chao, J. Corry, C. Laidlaw, K. Yuen, G. Ryan, D. Byram, S. Davis, J. Kiffer, G. Quong, et al. Mantle Irradiation Alone for Clinical Stage I-II Hodgkin's Disease: Long-Term Follow-Up and Analysis of Prognostic Factors in 261 Patients J. Clin. Oncol., January 1, 1999; 17(1): 230 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Joseph, R. Clark, C. Berman, M. Miller, C. Cox, H. Greenberg, and D. S. Reintgen Screening Childhood Cancer Survivors for Breast Cancer Oncologist, August 1, 1997; 2(4): 228 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Curtis, P. A. Rowlings, H. J. Deeg, D. A. Shriner, G. Socie, L. B. Travis, M. M. Horowitz, R. P. Witherspoon, R. N. Hoover, K. A. Sobocinski, et al. Solid Cancers after Bone Marrow Transplantation N. Engl. J. Med., March 27, 1997; 336(13): 897 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Mirer, H. Ekert, L. B. Travis, R. E. Curtis, J. D. Boice, S. Bhatia, L. L. Robison, A. T. Meadows, S. S. Donaldson, and S. L. Hancock Late Effects of Treatment for Childhood Hodgkin's Disease N. Engl. J. Med., August 1, 1996; 335(5): 352 - 355. [Full Text]
|
|
|
|
|
|
S. Bhatia, L. L. Robison, O. Oberlin, M. Greenberg, G. Bunin, F. Fossati-Bellani, and A. T. Meadows Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease N. Engl. J. Med., March 21, 1996; 334(12): 745 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Donaldson and S. L. Hancock Second Cancers after Hodgkin's Disease in Childhood N. Engl. J. Med., March 21, 1996; 334(12): 792 - 794. [Full Text]
|
|
|
|
|
|
P. S. Multani and M. L. Grossbard Staging Laparotomy in the Management of Hodgkin's Disease: Is it Still Necessary? Oncologist, February 1, 1996; 1(1): 41 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Boice Jr, J. S. Mandel, and M. M. Doody Breast Cancer Among Radiologic Technologists JAMA, August 2, 1995; 274(5): 394 - 401. [Abstract] [PDF]
|
|